A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
Public ClinicalTrials.gov record NCT06095505. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
Study identification
- NCT ID
- NCT06095505
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Puma Biotechnology, Inc.
- Industry
- Enrollment
- 120 participants
Conditions and interventions
Conditions
Interventions
- Alisertib Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 7, 2024
- Primary completion
- Oct 29, 2027
- Completion
- Apr 29, 2028
- Last update posted
- Jun 4, 2026
2024 – 2028
United States locations
- U.S. sites
- 30
- U.S. states
- 21
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Southern Cancer Center | Daphne | Alabama | 36526 | Recruiting |
| The Oncology Institute of Hope and Innovation | Long Beach | California | 90805 | Recruiting |
| Rocky Mountain Cancer Centers | Lone Tree | Colorado | 80124 | Recruiting |
| Georgetown Lombardi Cancer Center | Washington D.C. | District of Columbia | 20057 | Recruiting |
| Clermont Oncology Center | Clermont | Florida | 64711 | Recruiting |
| The Oncology Institute of Hope and Innovation | Fort Lauderdale | Florida | 33316 | Recruiting |
| Moffitt Cancer Center | Tampa | Florida | 33612 | Recruiting |
| Illinois Cancer Specialists | Niles | Illinois | 60714 | Recruiting |
| Indiana University Melvin and Bren Simon Comprehensive Cancer Center | Indianapolis | Indiana | 46202 | Recruiting |
| University of Maryland Greenebaum Comprehensive Cancer Center | Baltimore | Maryland | 21201 | Recruiting |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | Recruiting |
| Dana Farber Cancer Institute | Boston | Massachusetts | 02215 | Recruiting |
| Henry Ford Hospital | Detroit | Michigan | 48202 | Recruiting |
| Minnesota Oncology Hematology | Burnsville | Minnesota | 55337 | Recruiting |
| Nebraska Cancer Specialists | Grand Island | Nebraska | 68803 | Recruiting |
| Oncology Hematology Care Clinical Trials | Cincinnati | Ohio | 45226 | Recruiting |
| University Hospital - Cleveland Medical Center | Cleveland | Ohio | 44106 | Recruiting |
| Cleveland Clinic | Cleveland | Ohio | 44195 | Active, not recruiting |
| Zangmeister Cancer Center | Columbus | Ohio | 43219 | Recruiting |
| Oncology Associates of Oregon | Eugene | Oregon | 97401 | Recruiting |
| UPMC Hillman Cancer Center | Pittsburgh | Pennsylvania | 15232 | Withdrawn |
| Medical University of South Carolina Hollings Cancer Center | Charleston | South Carolina | 29425 | Recruiting |
| SCRI Oncology Partners | Nashville | Tennessee | 37203 | Recruiting |
| Texas Oncology-Baylor Charles A. Sammons Cancer Center | Dallas | Texas | 75246 | Recruiting |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390 | Recruiting |
| Oncology & Hematology Associates of Southwest Virginia | Blacksburg | Virginia | 24073 | Recruiting |
| Universtity of Virginia Health System | Charlottesville | Virginia | 22908 | Completed |
| Virginia Cancer Specialists Research Institute | Fairfax | Virginia | 22031 | Recruiting |
| Northwest Cancer Specialists | Vancouver | Washington | 98686 | Recruiting |
| Marshfield Medical Center | Marshfield | Wisconsin | 54449 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06095505, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 4, 2026 · Synced Jun 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06095505 live on ClinicalTrials.gov.